HS
HZNP

HighVista Strategies’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

HighVista Strategies’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-34,954
Closed -$4.04M – 156
2023
Q3 		$4.04M Hold
34,954
– – 1.87% 7
2023
Q2 		$3.6M Buy
34,954
+5,954
+21% +$628K 1.64% 10
2023
Q1 		$3.17M Buy
+29,000
New +$3.21M 2.58% 8
2022
Q4 		– Sell
-13,055
Closed -$808K – 138
2022
Q3 		$808K Buy
13,055
+5,636
+76% +$394K 0.46% 58
2022
Q2 		$592K Sell
7,419
-837
-10% -$79.3K 0.36% 70
2022
Q1 		$869K Sell
8,256
-3,042
-27% -$296K 0.55% 50
2021
Q4 		$1.22M Hold
11,298
– – 0.97% 32
2021
Q3 		$1.24M Buy
11,298
+2,619
+30% +$272K 0.82% 33
2021
Q2 		$813K Buy
8,679
+91
+1% +$8.37K 0.58% 43
2021
Q1 		$790K Buy
+8,588
New +$725K 0.59% 28

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HighVista Strategies's HZNP Position: Q4 2023 in Review

HighVista Strategies sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 34,954 shares — an estimated $4.04M sold.

HighVista Strategies first reported a position in HZNP in Q1 2021 and held it in 10 quarters. The position peaked at $4.04M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • HighVista Strategies reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • HighVista Strategies sold 34,954 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $4.04M.
  • HighVista Strategies first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 10 quarters.
  • HighVista Strategies's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.04M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on HighVista Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.